Brain and Development
Volume 34, Issue 3 , Pages 230-233, March 2012

Spinocerebellar ataxias type 27 derived from a disruption of the fibroblast growth factor 14 gene with mimicking phenotype of paroxysmal non-kinesigenic dyskinesia

  • Keiko Shimojima

      Affiliations

    • Tokyo Women’s Medical University Institute for Integrated Medical Sciences, Tokyo, Japan
  • ,
  • Akihisa Okumura

      Affiliations

    • Department of Pediatrics, Juntendo University School of Medicine, Tokyo, Japan
  • ,
  • Jun Natsume

      Affiliations

    • Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan
  • ,
  • Kaori Aiba

      Affiliations

    • Department of Pediatrics, Toyohashi Municipal Hospital, Toyohashi, Japan
  • ,
  • Hirokazu Kurahashi

      Affiliations

    • Department of Pediatric Neurology, Aichi Prefectural Colony Central Hospital, Kasugai, Japan
  • ,
  • Tetsuo Kubota

      Affiliations

    • Department of Pediatrics, Anjo Kosei Hospital, Anjo, Japan
  • ,
  • Kenji Yokochi

      Affiliations

    • Department of Pediatrics, Seirei-Mikatahara General Hospital, Hamamatsu, Shizuoka, Japan
  • ,
  • Toshiyuki Yamamoto

      Affiliations

    • Tokyo Women’s Medical University Institute for Integrated Medical Sciences, Tokyo, Japan
    • Corresponding Author InformationCorresponding author. Address: Tokyo Women’s Medical University Institute for Integrated Medical Sciences, 8-1 Kawada-cho, Shinjuku-ward, Tokyo 162-8666, Japan. Tel.: +81 3 3353 8111x24013; fax: +81 3 5269 7667.

Received 17 November 2010; received in revised form 27 April 2011; accepted 27 April 2011. published online 20 May 2011.

Abstract 

Many types of spinocerebellar ataxias (SCAs) manifest as progressive disorders with cerebellar involvement. SCA type 27 (SCA27) is a rare type of SCA caused by mutations in the fibroblast growth factor 14 gene (FGF14). FGF14 disruption caused by a de novo reciprocal chromosomal translocation between chromosomes 13 and 21 was identified in a patient with the phenotype of paroxysmal non-kinesigenic dyskinesia (PNKD). This indicated genetic heterogeneity of PNKD, since 60% of the patients with PNKD exhibit mutations in another gene responsible for PNKD, the myofibrillogenesis regulator 1 gene (MR-1). We hypothesized that the remaining 40% of patients with PNKD may have FGF14 mutations; therefore, the nucleotide sequences of MR-1 and FGF14 were analyzed in another six patients with PNKD, but no nucleotide alterations were observed in these genes for these patients. Further studies should be conducted on the phenotypic heterogeneity of FGF14 mutations and/or haploinsufficiency in SCA27 and PNKD.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0387-7604(11)00133-1

doi:10.1016/j.braindev.2011.04.014

Brain and Development
Volume 34, Issue 3 , Pages 230-233, March 2012